GEN Exclusives

More »

GEN News Highlights

More »
Sep 25, 2008

Clarient Allys with Definiens for Image Analysis Tools for Use in Cancer Diagnostics

  • Clarient and Definiens will partner to employ a series of image analysis platforms for Clarient's in-house R&D and web-based customer portal PATHSiTE. The five-year agreement is focused on developing and commercializing tools to evaluate quantitative biomarkers that predict response to targeted cancer therapies.

    The collaboration involves seamlessly integrating a wide range of image analysis tools into Clarient's existing infrastructure. Clarient says this will increase operational throughput with automated analysis of tissue sample images of all sizes, support cancer tissue biomarker profiling, and facilitate streamlined diagnoses.

    Clarient processes tissue samples for biomarkers for both clinical decision-making and biopharmaceutical development. The tissue samples are stored as high-resolution digital images that are managed and analyzed with PATHSiTE.

    Definiens' platform utilizes image analysis algorithms to analyze multidimensional image data. The software automatically identifies and quantifies regions of interest within breast, prostate, and colon cancer tissue samples including nuclei and membranes protein quantification.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Patient Access to Genetic Information

Do you think patients have the absolute right to gain access to their own genetic information from medical or clinical laboratories?

More »